Cidara Therapeutics, Inc.

Historical 13F Holders

Symbol
CDTX
CUSIP
171757206
All holders as of
Q4 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 171757206 since 12/18/2024, largest first.

Filer % of Class Filed
Vanguard Group Inc 13G 6.4% 1/30/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (12)
Adage Capital Management, L.P. 13G/A
4.97% 8/12/2025
Event 6/30/2025
BlackRock, Inc. 13G/A 4.6% 10/17/2025
Event 9/30/2025
Biotechnology Value Fund L P 13G/A
4.4% 10/17/2025
Event 10/15/2025
Paradigm Biocapital Advisors LP 13G/A
3.3% 11/14/2025
Event 9/30/2025
Venrock Healthcare Capital Partners III, L.P. 13G/A
3.2% 8/14/2025
Event 6/30/2025
Commodore Capital LP 13G/A
2.0% 11/14/2025
Event 9/30/2025
Point72 Asset Management, L.P. 13G/A
1.4% 2/17/2026
Event 12/31/2025
BCLS Fund III Investments, LP 13G/A 0% 2/17/2026
Event 12/31/2025
Canaan XII L.P. 13G/A
0% 8/14/2025
Event 6/30/2025
RA Capital Management, L.P. 13D/A
0% 1/9/2026
Event 1/7/2026
TCG Crossover GP II, LLC 13G/A
0% 11/14/2025
Event 9/30/2025
Vivo Opportunity Fund Holdings, L.P. 13G/A
0% 2/13/2026
Event 1/7/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q4 258 33.3 M $7.35B
2025 Q3 168 32.5 M $3.11B
2025 Q2 110 25.9 M $1.26B
2025 Q1 48 9.56 M $206M
2024 Q4 42 6.87 M $184M
2024 Q3 29 3.31 M $35.6M
2024 Q2 26 1.41 M $16.9M